Xu J, Bai Y, Xu N, Li E, et al. Tislelizumab Plus Chemotherapy as First-line Treatment for Advanced Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma. Clin Cancer Res 2020 Jun 19. pii: 1078-0432.CCR-19-3561.
PMID: 32561664